1. Response Evaluation: Beyond RECIST Elizabeth Eisenhauer MD FRCPC ESMO Conference Lugano 07 July 2007 2. Outline Background:Why measure response? Response criteria in cancer…

1. Response evaluation in solid tumors PRESENTER: DR.B.SATHISH(JR,1ST Yr RT)MODERATOR:DR.ASHUTOSH MUKHERJEE,Asst Prof RT 2. Why Measure Response?The word “response” is…

1. AASLD 2011BLINDED INDEPENDENT CENTRAL RESPONSE ASSESSMENT USING RECIST, MODIFIED RECIST, AND CHOI CRITERIA IN PATIENTS TREATED WITH SORAFENIB FOR ADVANCEDHEPATOCELLULAR…

1. 1 2. © CDISC 2014 Angelo Tinazzi, Cytel Inc, Geneva, Switzerland 2 Therapeutic Area Standards – Reflections on Oncology standards and what is needed in the future Geneva…

Slide 1GDC-0449 in Patients With Advanced Chondrosarcomas: a French Sarcoma Group / French and US NCI phase II collaborative study Antoine Italiano, Axel Le Cesne, Jean-Yves…

Slide 1 PET/CT Imaging and Cancer Response to Treatment Dr. François Bénard Slide 2 Potential Conflict of Interest None Slide 3 PET/CT imaging and cancer response to treatment…

Slide 1 Attenuation of Treatment Effect Due to Measurement Variability in Assessment of Progression-Free Survival Pharmaceut. Statist. 2012, 11 394–402 Nicola Schmitt,…

Slide 1 ALMA MATER STUDIORUM UNIVERSITÀ DI BOLOGNA Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola-Malpighi RESPONSE PREDICTORS TO TARGETED THERAPIES Stefano…

Imaging Workspace Roadmap Imaging Workspace Roadmap Eliot Siegel, M.D. Professor and Vice Chair University of Maryland School of Medicine Department of Diagnostic Radiology…

CONFIRM 2 INTERIM ANALYSIS Results of an Interim Analysis of a Multinational Randomized, Double-Blind, Phase III Study in Patients With Previously Treated Metastatic Colorectal…